Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 7 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 11312787

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  2. US 11299517

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  3. US 11298413

    Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof

    IO Biotech ApS · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  4. US 11286282

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  5. US 11285204

    Tobamovirus-based virus-like particles and vaccines

    THE GOVERNMENT OF THE UNITED STATES, AS REPRESEN · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  6. US 11274149

    Anti-CD100 antibodies and methods for using the same

    VACCINEX, INC. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  7. US 11260120

    Immunogenic composition comprising a fusion peptide derived from superantigen toxoids

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  8. US 11254713

    Method to enhance immunogenicity of live typhoid vaccines and carriers

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  9. US 11235044

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  10. US 11235054

    Multivalent vaccine composition

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  11. US 11224645

    Glycoconjugate vaccine for leishmaniasis

    The Board of Regents of the University of Texas System · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  12. US 11224647

    Safe potent single platform vaccine against Tier 1 select agents and other pathogens

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  13. US 11224646

    Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  14. US 11214603

    C3D cellular and acellular vaccines for the prevention and treatment of cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  15. US 11202823

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  16. US 11197923

    Methods and compositions for live attenuated viruses

    Takeda Vaccines, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  17. US 11191821

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  18. US 11191727

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  19. US 11185581

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  20. US 11180765

    Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  21. US 11167025

    Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  22. US 11154601

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  23. US 11154606

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  24. US 11155834

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.